NZ184931A - Pharmaceutical composition comprising a low viscosity sodium alginate: prevention of gastric reflux - Google Patents

Pharmaceutical composition comprising a low viscosity sodium alginate: prevention of gastric reflux

Info

Publication number
NZ184931A
NZ184931A NZ184931A NZ18493177A NZ184931A NZ 184931 A NZ184931 A NZ 184931A NZ 184931 A NZ184931 A NZ 184931A NZ 18493177 A NZ18493177 A NZ 18493177A NZ 184931 A NZ184931 A NZ 184931A
Authority
NZ
New Zealand
Prior art keywords
prevention
pharmaceutical composition
low viscosity
sodium alginate
gastric reflux
Prior art date
Application number
NZ184931A
Other languages
English (en)
Inventor
R Withington
Original Assignee
Reckitt & Colmann Prod Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Reckitt & Colmann Prod Ltd filed Critical Reckitt & Colmann Prod Ltd
Publication of NZ184931A publication Critical patent/NZ184931A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0065—Forms with gastric retention, e.g. floating on gastric juice, adhering to gastric mucosa, expanding to prevent passage through the pylorus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
NZ184931A 1976-11-09 1977-08-16 Pharmaceutical composition comprising a low viscosity sodium alginate: prevention of gastric reflux NZ184931A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB46543/76A GB1524740A (en) 1976-11-09 1976-11-09 Pharmaceutical compositions for use in the suppression of gastric reflux

Publications (1)

Publication Number Publication Date
NZ184931A true NZ184931A (en) 1979-06-08

Family

ID=10441659

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ184931A NZ184931A (en) 1976-11-09 1977-08-16 Pharmaceutical composition comprising a low viscosity sodium alginate: prevention of gastric reflux

Country Status (15)

Country Link
US (1) US4140760A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
JP (1) JPS5359016A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AU (1) AU509823B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
BE (1) BE858003A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CA (1) CA1083964A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CY (1) CY1131A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DE (1) DE2738014A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
FR (1) FR2369843A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
GB (1) GB1524740A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
HK (1) HK59681A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
IE (1) IE45655B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
KE (1) KE3175A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
NL (1) NL188892C (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
NZ (1) NZ184931A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
ZA (1) ZA774920B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)

Families Citing this family (65)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3228231A1 (de) * 1982-07-28 1984-02-02 Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V., 8000 München Arzneimittel, calciummischsalze von polymeren, anionischen carbonsaeuren und/oder schwefelsaeureestern, verfahren zu ihrer herstellung und ihre verwendung
GB8323624D0 (en) * 1983-09-02 1983-10-05 Reckitt & Colmann Prod Ltd Medicinal compositions
US4613497A (en) * 1984-02-29 1986-09-23 Health Products Development, Inc. Dry, water-foamable pharmaceutical compositions
DE3586281T2 (de) * 1984-04-19 1992-12-10 Rhone Poulenc Rorer Int Antisaeurezusammensetzung.
US4869902A (en) * 1984-04-19 1989-09-26 Rorer Pharmaceutical Corporation Antacid composition
NZ215069A (en) * 1985-03-01 1988-06-30 Reckitt & Colmann Prod Ltd Pharmaceutical composition with histamine h 2 -receptor antagonist
US5254591A (en) * 1986-01-03 1993-10-19 The University Of Melbourne Pharmaceutical composition for treating gastroesophageal reflux
AU594424B2 (en) * 1986-01-03 1990-03-08 University Of Melbourne, The Gastro-oesophageal reflux composition
US5112813A (en) * 1986-03-07 1992-05-12 Rhone-Poulenc Rorer Pharmaceuticals Inc. Process for the preparation of a viscosity-stable antacid composition
US4744986A (en) * 1986-03-07 1988-05-17 Rorer Pharmaceutical Corporation Process for the preparation of a viscosity-stable antacid composition
US5002777A (en) * 1986-06-24 1991-03-26 Norcliff Thayer Inc. Encapsulated antacid
DK179687D0 (da) * 1987-04-08 1987-04-08 Farma Food As Praeparat
NL8902338A (nl) * 1988-09-20 1990-04-17 Glaxo Group Ltd Farmaceutische preparaten.
US5460803A (en) * 1989-05-24 1995-10-24 American Dental Association Health Foundation Methods and compositions for mineralizing and fluoridating calcified tissues
US5827247A (en) * 1991-08-20 1998-10-27 Bioderm External incontinence device and vapor-absorptive adhesive compositions
US5360793A (en) * 1993-05-24 1994-11-01 Sterling Winthrop Inc. Rafting antacid formulation
US5427768A (en) * 1993-06-23 1995-06-27 American Dental Association Health Foundation Carbonated solutions for treating, mineralizing and fluoridating calcified tissues and methods for their use
US5455050A (en) * 1993-11-12 1995-10-03 Mcneil-Ppc, Inc. Aqueous antacids with calcium carbonate and magnesium salt
GB9504599D0 (en) * 1995-03-03 1995-04-26 Reckitt & Colmann Prod Ltd Improvements in or relating to organic compositions
US6099871A (en) * 1995-06-01 2000-08-08 Bristol-Myers Squibb Company Anti-regurgitation infant formula
EP0979091A1 (en) 1997-04-30 2000-02-16 Reckitt Benckiser Healthcare (UK) Limited Pourable alginate compositions
GB9708772D0 (en) * 1997-04-30 1997-06-25 Reckitt & Colmann Prod Ltd Organic compositions
WO1999045937A1 (en) * 1998-03-11 1999-09-16 Smithkline Beecham Corporation Process of making an aqueous calcium carbonate suspension
US20030220258A1 (en) * 2001-12-21 2003-11-27 Robbert Benner Treatment of ischemic events
GB9812426D0 (en) * 1998-06-10 1998-08-05 Reckitt & Colmann Prod Ltd Improvements in or relating to organic compositions
GB0005743D0 (en) 2000-03-10 2000-05-03 Reckitt & Colmann Prod Ltd Pharmaceutical compositions including alginates
US7358330B2 (en) * 2001-03-29 2008-04-15 Biotempt B.V. Immunoregulatory compositions
GB0012094D0 (en) * 2000-05-19 2000-07-12 Reckitt & Colmann Prod Ltd Pharmaceutical compositions
US20030165606A1 (en) * 2001-07-18 2003-09-04 Lasekan John B. Anti-regurgitation formula and uses thereof
SE0103613D0 (sv) * 2001-10-30 2001-10-30 Astrazeneca Ab Novel formulation
SE0103722D0 (sv) * 2001-10-30 2001-10-30 Astrazeneca Ab Novel formulation
US6989166B2 (en) * 2001-12-20 2006-01-24 N.V. Nutricia Soft drink replacer
US6779530B2 (en) 2002-01-23 2004-08-24 Schweitzer-Mauduit International, Inc. Smoking articles with reduced ignition proclivity characteristics
GB2384986B (en) * 2002-02-12 2004-01-07 Reckitt Benckiser Healthcare Compositions for the treatment of disorders of the upper gastrointestinal tract
TR200300510A2 (tr) * 2003-04-18 2004-11-22 Sanovel �La� Sanay� Ve T�Caret A.�. Dağılan alendronat mikropartikül formülasyonu
US7198653B2 (en) 2003-07-31 2007-04-03 Delavau Llc Calcium carbonate granulation
DE102004063612B4 (de) * 2004-01-02 2017-01-12 Manfred Helms Gelartiges Basenpräparat sowie Verwendung eines Gelbildners zu dessen Herstellung
US20060073202A1 (en) * 2004-10-05 2006-04-06 Rocca Jose G Dual component medicament delivery system
US8151806B2 (en) * 2005-02-07 2012-04-10 Schweitzer-Mauduit International, Inc. Smoking articles having reduced analyte levels and process for making same
GB0515492D0 (en) * 2005-07-28 2005-08-31 Reckitt Benckiser Healthcare Improvements in or relating to compositions,articles and methods
SE530605C2 (sv) * 2005-09-29 2008-07-15 Barbara Nelson Läkemedel innehållande ett syrahämmande medel, avseende att användas för att motverka och bota luftvägssjukdomar
ATE545341T1 (de) * 2005-10-05 2012-03-15 Fmc Biopolymer As Gelierungszusammensetzungen und -verfahren
EP1864692A1 (en) * 2006-06-07 2007-12-12 Biotempt B.V. Use of peptides for the control of radiation injury
IL175338A0 (en) * 2006-05-01 2006-09-05 Biota Ltd Orally administrable films and preparation thereof
EP2031990B1 (en) * 2006-06-01 2017-07-26 Schweitzer-Mauduit International, Inc. Free air burning smoking articles with reduced ignition proclivity characteristics
US9138414B1 (en) 2006-09-15 2015-09-22 Delavau Llc Calcium supplement having enhanced absorption
US20090148530A1 (en) 2007-12-08 2009-06-11 Jamie Koufman Method for prevention and treatment of reflux injury in the aerodigestive tract and laryngopharynx caused by pepsin
AU2011242177B8 (en) * 2010-04-23 2015-06-04 S-Biotek Holding Aps A solid pharmaceutical composition for neutralizing stomach acid
PL2806880T5 (pl) 2012-01-27 2020-09-07 Institute Of Bioorganic Chemistry Kompozycja farmaceutyczna jako substancja do przeciwrefluksowego leku zobojętniającego kwas
ITRM20120041A1 (it) 2012-02-08 2013-08-09 Dicofarm Spa "prodotto a base di glucomannano e chitosano utile per il trattamento del reflusso gastroesofageo"
RU2479318C1 (ru) * 2012-03-29 2013-04-20 Общество с ограниченной ответственностью "ВИТТА" (ООО "ВИТТА") Способ получения лекарственных и биологически активных средств
KR101417287B1 (ko) * 2012-06-15 2014-07-08 동아제약 주식회사 신규한 위식도역류질환 치료용 조성물
WO2014015240A1 (en) * 2012-07-19 2014-01-23 Sorbent Therapeutics, Inc. Compositions comprising crosslinked cation-binding polymers
JP5939943B2 (ja) 2012-09-14 2016-06-22 ヤンマー株式会社 エンジン装置
CN104797147B (zh) 2012-10-11 2019-08-13 施韦特-莫迪国际公司 具有降低引燃倾向特性的包装材料
KR102303835B1 (ko) * 2014-01-08 2021-09-16 영진약품 주식회사 수성의 유동성 액체 조성물 및 이의 제조방법
ITUB20159732A1 (it) * 2015-12-22 2017-06-22 S I I T S R L Servizio Int Imballaggi Termosaldanti Composizioni orali per il trattamento della malattia da reflusso gastroesofageo
FR3071728B1 (fr) 2017-09-29 2019-09-27 Laboratoires Arkopharma Composition adaptee pour former un radeau gastrique gelifie
EP3758716A4 (en) * 2018-03-02 2022-03-09 Pharagen LLC Formulations treating acid reflux comprising sodium alginate
CN114191307A (zh) 2020-09-17 2022-03-18 上海汉都医药科技有限公司 一种口腔滞留装置及其制备方法
US11911513B2 (en) 2018-05-23 2024-02-27 Shanghai Wd Pharmaceutical Co., Ltd Controlled-release system of active pharmaceutical ingredient and preparation method therefor
JP7125791B2 (ja) 2018-05-23 2022-08-25 シャンハイ ダブリュディー ファーマシューティカル カンパニー，リミティド 活性薬物成分の放出制御システムおよびその製造方法
CN115777783A (zh) * 2022-07-04 2023-03-14 浙江上方生物科技有限公司 一种防止胃食管倒流的健康饮料及其制备方法
JP2025525831A (ja) * 2022-08-02 2025-08-07 ニュートリション アンド バイオサイエンシズ ユーエスエー １，リミティド ライアビリティ カンパニー アルギネートをベースとする放出調節組成物
JP2025525127A (ja) 2022-08-02 2025-08-01 ニュートリション アンド バイオサイエンシズ ユーエスエー １，リミティド ライアビリティ カンパニー 抗逆流液体製剤の新規なアルギン酸塩及びセルロース誘導体ベースの組成物

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3330729A (en) * 1963-10-04 1967-07-11 Goodrich Co B F Sustained release tablet containing medicament admixed in a waterinsoluble acrylic acid cross-linked polymer and selected basic magnesium or calcium diluent
US3326755A (en) * 1965-06-15 1967-06-20 Warner Lambert Pharmaceutical Alginate containing antacid compositions
US3767794A (en) * 1969-11-21 1973-10-23 Richardson Merrell Inc Antifoam preparations and method of preparing same
JPS5176415A (en) * 1974-12-26 1976-07-02 Riken Vitamin Oil Co Ltd Choyoseiseizaino seizohoho

Also Published As

Publication number Publication date
DE2738014A1 (de) 1978-05-18
BE858003A (fr) 1977-12-16
NL188892C (nl) 1992-11-02
JPS5359016A (en) 1978-05-27
IE45655B1 (en) 1982-10-20
ZA774920B (en) 1979-03-28
AU509823B2 (en) 1980-05-29
CY1131A (en) 1982-05-07
FR2369843B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1980-12-26
GB1524740A (en) 1978-09-13
IE45655L (en) 1978-05-09
JPS646172B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1989-02-02
FR2369843A1 (fr) 1978-06-02
KE3175A (en) 1982-01-08
CA1083964A (en) 1980-08-19
NL7709307A (nl) 1978-05-11
AU2830677A (en) 1979-03-08
HK59681A (en) 1981-12-11
DE2738014C2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1988-08-18
US4140760A (en) 1979-02-20

Similar Documents

Publication Publication Date Title
NZ184931A (en) Pharmaceutical composition comprising a low viscosity sodium alginate: prevention of gastric reflux
SG61784G (en) Nasal pharmaceutical compositions
JPS5210415A (en) Anodyne for intraintestinal administration and its preparation
ZA771091B (en) Pharmaceutical compositions
PT66622A (en) Pharmaceutical compositions
NZ183390A (en) Acaricidal pharmaceutical compositions containing pyrethrinoides
IL49325A0 (en) Novel prostaglandin derivatives,their preparation and pharmaceutical compositions containing them
IL52622A0 (en) Novel diaryl alkyl diethers and -thioethers,their preparation and pharmaceutical compositions containing them
NZ184539A (en) 2-bromo-6-fluoro-n-2-imidazolidinylidene-benzamine pharmaceutical compositions
NZ186147A (en) Sterolin pharmaceutical compositions
IL52792A0 (en) Novel thiophene derivatives their preparation and pharmaceutical compositions containing them
IL56435A0 (en) Pharmaceutical compositions containing prostaglandins
IL51428A (en) 3-substituted-4-aminoalkoxy-5,6-condensed ring-(2h)-pyran-2-ones,their preparation and pharmaceutical compositions containing them
IL53078A0 (en) New aryl sulphur compounds their preparation and pharmaceutical compositions containing them
IL51850A0 (en) Novel thiourea derivatives their preparation and pharmaceutical compositions containing them
AU2609277A (en) Pharmaceutical compositions
IL53559A0 (en) Novel prostaglandin analogues their preparation and pharmaceutical compositions containing them
GB1545039A (en) Oral anti-diabetic drug composition
ZA786132B (en) New gastric reflux suppressant pharmaceutical compositions
IL52103A0 (en) Pharmaceutical compositions containing naphthopyrane derivvatives
IL53560A0 (en) Novel prostaglandin analogues their preparation and pharmaceutical compositions containing them
PT66509B (en) Pharmaceutical compositions
HK69380A (en) Pharmaceutical compositions
AU2574877A (en) Pharmaceutical compositions
HK3984A (en) Pharmaceutical compositions